Connect with us

Business

Emyria (ASX:EMD) share price falling on news of MDMA therapy trial

Published

on

Shares in Emyria Ltd (ASX: EMD) are falling today after the company shared news of a psychedelic therapy program targeting post traumatic stress disorder (PTSD). At its intraday low, the Emyria share price has fallen by 5%.

At the time of writing, it has slightly recovered. Currently, the…



Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Article feature image
Morrison government to fund $600m gas-fired power plant in NSW Hunter region – The Guardian
Article feature image
Angus Taylor moves to allow renewable energy agency to fund carbon capture and hydrogen – The Guardian